REQUEST A DEMO
Total
USD $0.00
Search more companies

Baltacon SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Baltacon SIA Profile Updated: February 25, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Baltacon Ltd provides pharmaceutical supply solutions with a focus on sourcing, handling and distribution of medicines for clinical trials and healthcare supply needs. The company delivers services such as comparator sourcing, import and export support, worldwide storage and handling, distribution coordination and expert consultations, including support for veterinary clinical trial supply and shortage-related sourcing. Baltacon operates with international reach and positions its service model around customized supply-chain execution designed to ensure the right medicines are available at the right time for sponsors, CROs and healthcare partners.

Headquarters
Kruzes iela 38
Riga; Riga; Postal Code: 1002

Contact Details: Purchase the Baltacon SIA report to view the information.

Website: https://www.baltacon.lv/

Basic Information
Total Employees:
Purchase the Baltacon SIA report to view the information.
Registered Capital:
Purchase the Baltacon SIA report to view the information.
Financial Auditors:
Purchase the Baltacon SIA report to view the information.
Incorporation Date:
September 15, 2009
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Subsidiaries
Premium Rent SIA
100%
Abc Pharma SIA
50%
Nexmed SIA
33.33%
Company Performance
Financial values in the chart are available after Baltacon SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
38.05%
Total operating revenue
36.68%
Operating Profit/Loss (EBIT)
-9.34%
EBITDA
-9.34%
Net Profit/Loss for the Period
-2.76%
Total Assets
16.76%
Total Equity
17.68%
Operating Profit Margin (ROS)
-3.02%
Net Profit Margin
-3.07%
Return on Equity (ROE)
-4.29%
Quick Ratio
-0.53%
Cash Ratio
-0.38%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?